Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma

11 Mar 2023

Abstract excerpt

BACKGROUND: Glioma is the most common primary tumor in the human central nervous system. This study was designed to explore the expression of BZW1 in glioma and its relevance to the clinicopathological features and outcome of glioma patients. METHODS: Glioma transcription profiling data were obtained from The Cancer Genome Atlas (TCGA). TIMER2, GEPIA2, GeneMANIA, and Metascape were searched in the present study....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment
Share to Neurofibromatosis and Schwannoma Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36907429
DOI: 10.1016/j.ygeno.2023.110602

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in gliomaPMID 36907429Read ↗

Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients through bioinformatics analysis and experimental verificationSemantic proximity Read ↗

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in GliomasSemantic proximity Read ↗

DNAJC10 Correlates with Tumor Immune Characteristics and Predicts the Prognosis of Glioma PatientsSemantic proximity Read ↗

Crosstalk between CD180-overexpression macrophages and glioma cells worsens patient survival through malignant phenotype promotion and immunosuppressive regulation.Semantic proximity Read ↗

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in gliomaSemantic proximity Read ↗

TGIF1 overexpression promotes glioma progression and worsens patient prognosisSemantic proximity Read ↗

Prognostic value and drug sensitivity of FBXL6 in gliomaSemantic proximity Read ↗

TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.Semantic proximity Read ↗

Interaction with AEG-1 and MDM2 is associated with glioma development and progression and correlates with poor prognosisSemantic proximity Read ↗

MUL1, an Immune Chemokine-Related Gene, Regulates Glioma Cell Proliferation and Migration: Insights from Functional and Mechanistic StudiesSemantic proximity Read ↗

TEAD4 Serves as a Prognostic Biomarker and Correlates With Immune Phenotype in Lower-Grade GliomasSemantic proximity Read ↗

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.